Designing biologic selectivity for inflammatory bowel disease – role of vedolizumab
Niklas Krupka, Daniel C Baumgart Division of Gastroenterology and Hepatology, Department of Medicine, Charité Medical School, Humboldt-University of Berlin, Berlin, Germany Abstract: Crohn’s disease and ulcerative colitis are two chronic inflammatory bowel conditions. Current...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-12-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/designing-biologic-selectivity-for-inflammatory-bowel-disease-ndash-ro-peer-reviewed-article-DDDT |